
Novel клетка-permeable PDE7 ингибитор, targeting the cyclic adenosine monophosphate (cAMP)/cAMP-response element связывание protein (CREB) pathway, exerting neuroprotection in an Alzheimer's disease (AD) model
Novel cell-permeable PDE7 inhibitor, targeting the cyclic adenosine monophosphate (cAMP)/cAMP-response element binding protein (CREB) pathway, exerting neuroprotection in an Alzheimer's disease (AD) model
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.